Clinical trial
Non-interventional Study on the Quality of Life Before and After Intake of Sinolpan® (Forte) in Inflammatory Diseases of the Respiratory Tract - an Anonymous Patient Survey
NCT04703673 is registered in ClinicalTrials.gov with Engelhard Arzneimittel GmbH & Co.KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Study on the Quality of Life Before and After Intake of Sinolpan® (Forte) in Inflammatory Diseases of the Respiratory Tract - an Anonymous Patient Survey
- Lead sponsor
- Engelhard Arzneimittel GmbH & Co.KG
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 8, 2021
- Completion date
- April 30, 2022
- Enrollment
- 350 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bronchitis, rhinosinusitis acute, rhinosinusitis chronic